Skip to main content
. 2015 Mar 30;6(14):12505–12519. doi: 10.18632/oncotarget.3723

Table 2. Differentially expressed genes after 20 passages of continuous treatment with AGI-5198 (FDR<0.05).

The expression levels are shown in Reads per Kilobase per Million (RPKM)

Chr GeneID HT1080 p20 AGI-5198 (RKPM) HT1080 p20 control (RKPM) JJ012 p20 AGI-5198 (RKPM) JJ012 p20 control (RKPM)
Chr7 COL1A2 0.136 0.052 75.973 38.604
Chr19 RFPL4A 0.065 0.249 1.203 5.090
Chr9 PTGDS 0 0 33.285 11.424
Chr13 POSTN 0.070 0 0.785 0.190
Chr5 ADAMTS12 0.053 0.097 2.230 5.086
Chr14 IFI27 1.398 1.042 108.563 49.819
Chr9 CLIC3 0.832 0.418 37.160 17.884
Chr1 RYR2 0.226 0.372 0.648 1.296
Chr14 DIO2 0.074 0.080 3.360 10.739
Chr6 ROS1 0.028 0.081 0.169 0.457
HHS Vulnerability Disclosure